These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 19384952

  • 1. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
    Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC.
    Int J Cancer; 2009 Aug 15; 125(4):774-82. PubMed ID: 19384952
    [Abstract] [Full Text] [Related]

  • 2. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
    Ru P, Steele R, Nerurkar PV, Phillips N, Ray RB.
    Cancer Prev Res (Phila); 2011 Dec 15; 4(12):2122-30. PubMed ID: 21911444
    [Abstract] [Full Text] [Related]

  • 3. Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.
    Nian H, Bisson WH, Dashwood WM, Pinto JT, Dashwood RH.
    Carcinogenesis; 2009 Aug 15; 30(8):1416-23. PubMed ID: 19528666
    [Abstract] [Full Text] [Related]

  • 4. Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia).
    Yao X, Li J, Deng N, Wang S, Meng Y, Shen F.
    J Sep Sci; 2011 Nov 15; 34(21):3092-8. PubMed ID: 21994203
    [Abstract] [Full Text] [Related]

  • 5. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
    Luchman HA, Benediktsson H, Villemaire ML, Peterson AC, Jirik FR.
    PLoS One; 2008 Nov 15; 3(12):e3940. PubMed ID: 19081794
    [Abstract] [Full Text] [Related]

  • 6. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
    Puri M, Kaur I, Kanwar RK, Gupta RC, Chauhan A, Kanwar JR.
    Curr Mol Med; 2009 Dec 15; 9(9):1080-94. PubMed ID: 19747115
    [Abstract] [Full Text] [Related]

  • 7. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
    Meng Y, Liu S, Li J, Meng Y, Zhao X.
    Int J Nanomedicine; 2012 Dec 15; 7():3133-42. PubMed ID: 22802682
    [Abstract] [Full Text] [Related]

  • 8. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG, Hwang KA, Choi KC.
    Nutrients; 2018 Nov 16; 10(11):. PubMed ID: 30453545
    [Abstract] [Full Text] [Related]

  • 9. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro.
    Zhu F, Zhang P, Meng YF, Xu F, Zhang DW, Cheng J, Lin HH, Xi DH.
    Planta; 2013 Jan 16; 237(1):77-88. PubMed ID: 22983699
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S, Kumar A, Li K, Tzivion G, Levenson AS.
    Biochim Biophys Acta; 2015 Feb 16; 1853(2):265-75. PubMed ID: 25447541
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Kai L, Samuel SK, Levenson AS.
    Int J Cancer; 2010 Apr 01; 126(7):1538-48. PubMed ID: 19810103
    [Abstract] [Full Text] [Related]

  • 12. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
    Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, Limtrakul P, Shirai T.
    Food Chem Toxicol; 2012 Mar 01; 50(3-4):840-7. PubMed ID: 22266361
    [Abstract] [Full Text] [Related]

  • 13. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
    Zhou B, Wang J, Zheng G, Qiu Z.
    Food Chem Toxicol; 2016 Nov 01; 97():375-384. PubMed ID: 27725205
    [Abstract] [Full Text] [Related]

  • 14. Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats.
    Meng Y, Liu B, Lei N, Zheng J, He Q, Li D, Zhao X, Shen F.
    J Ethnopharmacol; 2012 Jan 31; 139(2):590-8. PubMed ID: 22172326
    [Abstract] [Full Text] [Related]

  • 15. Ribosome-Inactivating Protein α-Momorcharin Derived from Edible Plant Momordica charantia Induces Inflammatory Responses by Activating the NF-kappaB and JNK Pathways.
    Chen YJ, Zhu JQ, Fu XQ, Su T, Li T, Guo H, Zhu PL, Lee SK, Yu H, Tse AK, Yu ZL.
    Toxins (Basel); 2019 Nov 26; 11(12):. PubMed ID: 31779275
    [Abstract] [Full Text] [Related]

  • 16. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.
    Blando JM, Carbajal S, Abel E, Beltran L, Conti C, Fischer S, DiGiovanni J.
    Neoplasia; 2011 Mar 26; 13(3):254-65. PubMed ID: 21390188
    [Abstract] [Full Text] [Related]

  • 17. Ribosome inactivating protein and lectin from bitter melon (Momordica charantia) seeds: sequence comparison with related proteins.
    Wang H, Ng TB.
    Biochem Biophys Res Commun; 1998 Dec 09; 253(1):143-6. PubMed ID: 9875234
    [Abstract] [Full Text] [Related]

  • 18. Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα.
    Chen J, Zheng Z, Chen Y, Li J, Qian S, Shi Y, Sun L, Han Y, Zhang S, Yu K.
    PLoS One; 2016 Dec 09; 11(4):e0153330. PubMed ID: 27058040
    [Abstract] [Full Text] [Related]

  • 19. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ, Zuo GW, Feng ZQ, Zhao LC, Luo L, You ZM, Li DY, Xia J, Li J, Chen DL.
    Asian Pac J Cancer Prev; 2014 Dec 09; 15(18):7849-55. PubMed ID: 25292076
    [Abstract] [Full Text] [Related]

  • 20. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH.
    Int J Oncol; 2004 Jan 09; 24(1):25-31. PubMed ID: 14654937
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.